-
December 9, 2005 Lupin receives US FDA approval for Cefprozil Tablets
-
December 7, 2005 Lupin Limited places US $ 100 million Foreign Currency Convertible Bonds
-
December 1, 2005 Lupin receives USFDA approval for Cephalexin Capsules
-
November 28, 2005 Lupin Receives Approval For Conducting Phase II Trials For LLL-3348 (Desoris)
-
October 24, 2005 Lupin has entered into an agreement with GSK Philippines
-
October 19, 2005 Dr. Vijay Kelkar and Mr. R A Shah join Lupin Board
-
October 19, 2005 Lupin Q2FY06 Net Profit Soars 158% to Rs. 452 million
-
September 27, 2005 Lupin – Ranbaxy Sign TB deal
-
September 26, 2005 Lupin and Aspen Sign TB Deal
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications